Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Incyte JAK Inhibitor Shows Promising One-Month Data In Rheumatoid Arthritis

This article was originally published in The Pink Sheet Daily

Executive Summary

Phase IIb RA studies launch later this year; myelofibrosis update set for December ASH meeting.
Advertisement

Related Content

Phase II Diabetes Data Heighten Incyte’s Partnership Appeal
Phase II Diabetes Data Heighten Incyte’s Partnership Appeal
JAKs Are Better? Oral Inhibitors Could Beat Injected Biologics In RA
JAKs Are Better? Oral Inhibitors Could Beat Injected Biologics In RA
JAKs Are Better? Oral Inhibitors Could Beat Injected Biologics In RA
JAKs Are Better? Oral Inhibitors Could Beat Injected Biologics In RA
Roche’s Actemra Gets Advisory Committee Review
Incyte Will First Seek Myelofibrosis, Rheumatoid Arthritis Indications For Lead JAK Compound
Roche Files BLA For Rheumatoid Arthritis Therapy Actemra
Roche Files BLA For Rheumatoid Arthritis Therapy Actemra

Topics

Advertisement
UsernamePublicRestriction

Register

PS067900

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel